Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.

Neumann AM, Blondell RD, Jaanim├Ągi U, Giambrone AK, Homish GG, Lozano JR, Kowalik U, Azadfard M.

J Addict Dis. 2013;32(1):68-78. doi: 10.1080/10550887.2012.759872.

2.

Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.

Curcio F, Franco T, Topa M, Baldassarre C; Gruppo Responsabili UO Sert T.

Eur Rev Med Pharmacol Sci. 2011 Aug;15(8):871-4.

PMID:
21845796
3.

Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.

Rosenblum A, Cruciani RA, Strain EC, Cleland CM, Joseph H, Magura S, Marsch LA, McNicholas LF, Savage SR, Sundaram A, Portenoy RK.

J Opioid Manag. 2012 Nov-Dec;8(6):369-82. doi: 10.5055/jom.2012.0137.

4.

Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre.

Montesano F, Zaccone D, Battaglia E, Genco F, Mellace V.

Clin Drug Investig. 2010;30 Suppl 1:13-9. doi: 10.2165/11536040-000000000-00000.

PMID:
20450241
5.

Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.

Stimolo C, Favero VD, Zecchinato G, Buson R, Cusin D, Pellachin P, Simonetto P.

Clin Drug Investig. 2010;30 Suppl 1:27-31. doi: 10.2165/11536030-000000000-00000.

PMID:
20450243
6.
7.

Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Roux P, Sullivan MA, Cohen J, Fugon L, Jones JD, Vosburg SK, Cooper ZD, Manubay JM, Mogali S, Comer SD.

Pain. 2013 Aug;154(8):1442-8. doi: 10.1016/j.pain.2013.05.004. Epub 2013 May 7.

8.

Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.

Rosado J, Walsh SL, Bigelow GE, Strain EC.

Drug Alcohol Depend. 2007 Oct 8;90(2-3):261-9. Epub 2007 May 22.

9.

Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model.

Pade PA, Cardon KE, Hoffman RM, Geppert CM.

J Subst Abuse Treat. 2012 Dec;43(4):446-50. doi: 10.1016/j.jsat.2012.08.010. Epub 2012 Sep 11.

PMID:
22980449
10.

Urine Spiking in a Pain Medicine Clinic: An Attempt to Simulate Adherence.

Lee D, Bazydlo LA, Reisfield GM, Goldberger BA.

Pain Med. 2015 Jul;16(7):1449-51. doi: 10.1111/pme.12663. Epub 2014 Dec 18. No abstract available.

PMID:
25522892
11.

Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.

Magnelli F, Biondi L, Calabria R, Fiore A, Peluso E, Vonella D, Rota AG.

Clin Drug Investig. 2010;30 Suppl 1:21-6. doi: 10.2165/11536010-000000000-00000.

PMID:
20450242
12.

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.

Hser YI, Saxon AJ, Huang D, Hasson A, Thomas C, Hillhouse M, Jacobs P, Teruya C, McLaughlin P, Wiest K, Cohen A, Ling W.

Addiction. 2014 Jan;109(1):79-87. doi: 10.1111/add.12333. Epub 2013 Oct 9.

13.
14.

Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.

Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD.

Drug Alcohol Depend. 2013 Jul 1;131(1-2):112-8. doi: 10.1016/j.drugalcdep.2012.12.010. Epub 2013 Jan 18.

15.

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers.

Strain EC, Stoller K, Walsh SL, Bigelow GE.

Psychopharmacology (Berl). 2000 Mar;148(4):374-83.

PMID:
10928310
16.

Use and misuse of opioid replacement therapies: a Queensland study.

Smirnov A, Kemp R.

Subst Use Misuse. 2012 Jan;47(1):78-85. doi: 10.3109/10826084.2011.629017.

PMID:
22216993
17.

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

J Clin Psychopharmacol. 1996 Feb;16(1):58-67.

PMID:
8834420
18.

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE.

N Engl J Med. 2000 Nov 2;343(18):1290-7.

19.

[Analgesic management of acute pain in patients receiving methadone or buprenorphine].

Zinck L, Sonne NM, Madsen SL, Nikolajsen L.

Ugeskr Laeger. 2015 Mar 2;177(10). pii: V10140557. Review. Danish.

PMID:
25749118
20.

Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.

Moratti E, Kashanpour H, Lombardelli T, Maisto M.

Clin Drug Investig. 2010;30 Suppl 1:3-11. doi: 10.2165/11536020-000000000-00000.

PMID:
20450240

Supplemental Content

Support Center